Toronto - Free Realtime Quote CAD
Eupraxia Pharmaceuticals Inc. (EPRX.TO)
5.30
+0.46
+(9.50%)
As of 3:57:29 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 8.04M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Direct | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Direct | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.61 per share. | Direct | 1,044 | Sep 10, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.73 per share. | Direct | 4,095 | Sep 4, 2024 |
| Montalbano (John S.) Director of Issuer | Acquisition or disposition in the public market at price 2.56 per share. | Direct | 37,873 | Jun 28, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.66 per share. | Direct | 2,926 | Jun 17, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.81 per share. | Direct | 2,248 | Jun 11, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.73 per share. | Direct | 2,730 | Jun 7, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 3.00 per share. | Direct | 1,920 | May 10, 2024 |
Related Tickers
MSCLF Satellos Bioscience Inc.
0.4500
-2.72%
SRZN Surrozen, Inc.
10.30
+8.76%
CYTO.V Cytophage Technologies Ltd.
0.1800
0.00%
ZYME Zymeworks Inc.
12.16
+3.49%
MSCL.TO Satellos Bioscience Inc.
0.6300
+1.61%
PHRM.CN PharmaTher Holdings Ltd.
0.1800
-5.26%
PLRZ Polyrizon Ltd.
0.3399
-7.38%
SLRX Salarius Pharmaceuticals, Inc.
0.6850
-0.74%
PHRRF PharmaTher Holdings Ltd.
0.1300
-10.34%
EDSA Edesa Biotech, Inc.
2.3200
-4.53%